SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001104659-20-031954
Filing Date
2020-03-11
Accepted
2020-03-11 16:30:36
Documents
1
Effectiveness Date
2020-03-11
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 13115
  Complete submission text file 0001104659-20-031954.txt   14430
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: D | Act: 33 | File No.: 021-362571 | Film No.: 20705645
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences